Direct quotation from the 2023 OMA guidelines: "Anti-obesity medication selection should be driven by efficacy data, individual patient response, side-effect profile, and access rather than by any single algorithm." OMA clinical practice guidelines are available at pubmed.ncbi.nlm.nih.gov
Your prescriber may have a different view from what this article references - and they should, because they know your specific situation
Only a few cases resulted in reduced C max with delayed t max of the investigated oral drug, findings that are consistent with the known effect of delayed gastric output by GLP1Ras
Serious adverse events were fewer in the semaglutide group (33.4% vs 36.4%), including cardiac disorders specifically (11.5% vs 13.5%)
H., & Van Gaal, L
Low vitamin D can cause symptoms like fatigue, bone or muscle aches, and in severe cases, weak bones